GL1X · GenesisL1 explorer

MolNFT v1 · #100793 · protein

Crystal structure of V30M mutant human transthyretin complexed with glabridin

4N87: “Crystal structure of V30M mutant human transthyretin complexed with glabridin”. X-ray diffraction, 1 ligand (GBJ), 2 pockets (best druggability 0.38). MolNFT v1 #100793 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
4N87
Type
protein
Length
230 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
GBJ
Pockets
2 · best druggability 0.38

Structure

x-ray diffraction · 1 distinct chain · 6% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BTransthyretinprotein1156% helix, 53% strandP02766

Ligands and binding sites

  • GBJ · 4-[(3R)-8,8-dimethyl-3,4-dihydro-2H,8H-pyrano[2,3-f]chromen-3-yl]benzene-1,3-diol · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1830.380.7717empty
2820.360.7617empty

Interfaces

1 interface between chains.

  • A–B · 922 Ų buried · 23 hydrogen bonds · protein-protein

Compared structures

  • 4N87 · Crystal structure of V30M mutant human transthyretin complexed with glabridin · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.